It’s the first new pharmaceutical approach to treating pain in more than 20 years, offering an alternative to both opioids ...
The Food and Drug Administration Jan. 30 announced it approved Journavx (suzetrigine) oral tablets, a first-in-class ...
Hosted on MSN13m
Non-Opioid Pain Medication Journavx Gets FDA ApprovalThe Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for ...
Suzetrigine (Journavx) is the first non-opioid pain medication to be approved in the US in 20 years. It could help over 80 million Americans living with severe acute pain, while reducing the effects ...
The U.S. Food and Drug Administration (FDA) has approved a new pain pill called Journavx, designed to mitigate the risks of addiction and overdose associated with opioid medications like Vicodin and ...
Vertex Pharmaceuticals (VRTX) is up more than +4% after receiving FDA approval for its non-opioid analgesic Journavx to treat moderate-to-severe acute pain in adults. LPL Financial Holdings (LPLA) is ...
The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback